Please find enclosed intimation regarding resignation of Chief Financial Officer.
Annual Secretarial Compliance Report for F. Y. 2025-26
Standalone and consolidated audited financial results for the quarter and year ended 31.03.2026 approved by the Board in their 01/2026-27 Board meeting held on 21.05.2026.An extract of the same published in Free Press Journal English edition and Choutha Sansar Hindi edition on 23.05.2026. Copy of the same being enclosed.
Re-appointment of internal Auditor for the financial year 2026-27
Submission of audited standalone and consolidated financial results for the quarter and year ended 31.03.2026
With reference to the above captioned subject and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board of Directors at their meeting held on today i.e. Thursday 21st May, 2026 has inter alia considered and approved: a) Audited Standalone and Consolidated Financial Results for the Fourth Quarter as well as financial year ended 31st March, 2026, b) Declaration regarding unmodified opinion of the Auditors on Annual Audited Financial Results of the Company, c)Re-Appointment of Praveen Shrivastava & Company, Chartered Accountants as an Internal Auditor of the Company for Financial Year 2026-27, d) Other routine businesses with the permission of Chair.
1.Consider and approve the Standalone as well as Consolidated Audited Financial Results of the Company for the fourth quarter as well as financial year ended on 31st March, 2026 along with auditor’s report thereon. 2.Consider other routine matters with the permission of chair.
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 regarding intimation to the shareholders holding shares in physical mode for mandatory furnishing of PAN, KYC, Bank and other details.
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedi Caps Ltd- 2CIN NO.L70100MP1983PLC002231 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ABHISHEK JAIN Designation: Company Secretary and Compliance Officer EmailId: investors@medicaps.com Name of the Chief Financial Officer: HEMANT SETHI Designation: CFO EmailId: accounts@medicaps.com Date: 08/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Information for shareholders regarding opening of Special window for Transfer and Dematerialization of Physical Securities.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 6.38 | 6.03 | 7.07 | 7.87 | 6.19 | 8.30 | 4.02 | 6.96 | 2.69 | 2.01 | 4.30 | 3.45 |
| YOY Revenue Growth % | -48.53% | -60.78% | -35.95% | -25.55% | -2.86% | 37.61% | -43.1% | -11.51% | -56.61% | -75.75% | 6.87% | -50.46% |
| Other Income | 0.07 | 0.07 | 0.09 | 0.24 | 0.15 | 0.29 | 0.16 | 2.14 | 0.33 | 1.53 | 0.76 | 5.59 |
| Total Income | 6.44 | 6.10 | 7.16 | 8.11 | 6.34 | 8.58 | 4.18 | 9.10 | 3.02 | 3.54 | 5.06 | 9.04 |
| Total Expenses + | 7.56 | 5.99 | 6.82 | 8.70 | 6.90 | 8.27 | 6.23 | 7.65 | 6.51 | 5.36 | 5.80 | 6.01 |
| Cost of Materials Consumed | 2.70 | 1.26 | 2.48 | 1.99 | 3.91 | 2.15 | 1.39 | 2.72 | 1.69 | 1.28 | 1.29 | 1.18 |
| Employee Benefit Expense | 1.79 | 1.73 | 1.47 | 2.08 | 1.72 | 1.88 | 1.79 | 2.20 | 1.86 | 1.85 | 1.86 | 2.17 |
| Other Expenses | 2.38 | 2.07 | 2.79 | 3.57 | 2.69 | 2.03 | 2.13 | 2.21 | 2.62 | 2.46 | 1.60 | 1.80 |
| Operating Profit | -1.18 | 0.04 | 0.25 | -0.83 | -0.70 | 0.03 | -2.20 | -0.69 | -3.83 | -3.35 | -1.50 | -2.56 |
| OPM % | -18.5% | 0.7% | 3.5% | -10.6% | -11.3% | 0.3% | -54.8% | -9.9% | -142.4% | -166.5% | -34.8% | -74.2% |
| Profit Before Tax + | -1.11 | 0.12 | 0.34 | -0.59 | -0.56 | 0.31 | -2.05 | 1.45 | -3.49 | -1.82 | -0.74 | 3.03 |
| Tax Expense | 0.00 | 0.00 | 0.51 | 0.49 | 0.00 | 0.00 | 0.00 | -0.27 | 0.00 | 0.00 | 0.03 | -0.01 |
| Tax % | - | 0% | 148.1% | - | - | 0% | - | -18.6% | - | - | - | -0.5% |
| Profit After Tax | -1.11 | 0.12 | -0.16 | -1.08 | -0.56 | 0.31 | -2.05 | 1.72 | -3.49 | -1.82 | -0.77 | 3.04 |
| EPS (Basic) | -0.89 | 0.09 | -0.13 | -0.86 | -0.45 | 0.25 | -1.64 | 1.38 | -2.80 | -1.46 | -0.61 | 2.44 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 12.45 | 25.48 | 27.35 | 49.37 | 69.87 | 58.72 |
| YOY Revenue Growth % | -51.14% | -6.83% | -44.61% | -29.34% | 18.99% | - |
| Other Income | 8.21 | 2.73 | 0.48 | 1.60 | 1.91 | 0.58 |
| Total Income | 20.66 | 28.21 | 27.82 | 50.97 | 71.79 | 59.30 |
| Total Expenses + | 23.68 | 29.05 | 29.07 | 46.05 | 61.73 | 48.06 |
| Cost of Materials Consumed | 5.44 | 10.17 | 8.43 | 22.05 | 30.05 | 31.08 |
| Employee Benefit Expense | 7.74 | 7.58 | 7.07 | 7.69 | 7.71 | 6.71 |
| Other Expenses | 8.48 | 9.07 | 10.79 | 13.71 | 22.09 | 10.47 |
| Operating Profit | -11.23 | -3.57 | -1.72 | 3.32 | 8.14 | 10.66 |
| OPM % | -90.2% | -14% | -6.3% | 6.7% | 11.7% | 18.1% |
| Profit Before Exceptional | -3.02 | -0.84 | -1.25 | 4.92 | 10.06 | 11.24 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | -3.02 | -0.84 | -1.25 | 4.92 | 10.06 | 11.24 |
| Tax Expense | 0.01 | -0.27 | 0.99 | 3.17 | -0.02 | 0.11 |
| Tax % | - | - | - | 64.3% | -0.2% | 1% |
| Profit After Tax | -3.04 | -0.57 | -2.24 | 1.76 | 10.08 | 11.13 |
| EPS (Basic) | -2.44 | -0.46 | -1.80 | 1.41 | 8.08 | 11.04 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 68.44 | 71.99 | 67.27 | 65.78 | 63.66 | 62.15 |
| Property, Plant & Equipment | 27.07 | 27.96 | 29.43 | 30.77 | 31.17 | 29.98 |
| Capital Work in Progress | 0.00 | 0.08 | 0.00 | 0.00 | 0.24 | 0.54 |
| Non-Current Investments | 12.49 | 15.42 | 9.32 | 6.49 | 3.72 | 3.12 |
| Goodwill | 28.14 | 28.14 | 28.14 | 28.14 | 28.14 | 28.14 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 47.02 | 53.44 | 60.01 | 60.20 | 66.69 | 52.67 |
| Inventories | 2.94 | 3.20 | 5.74 | 7.07 | 11.85 | 6.71 |
| Trade Receivables | 6.92 | 8.79 | 10.82 | 8.46 | 10.07 | 6.39 |
| Cash and Cash Equivalents | 0.50 | 0.41 | 0.32 | 1.11 | 0.00 | 0.00 |
| Current Investments | 23.41 | 28.70 | 30.14 | 25.59 | 26.96 | 26.30 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 111.61 | 121.28 | 120.98 | 118.57 | 116.26 | 104.71 |
| Equity Share Capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Other Equity | 99.14 | 108.81 | 108.51 | 106.10 | 103.79 | 92.24 |
| Non-Current Liabilities | 1.14 | 1.05 | 1.04 | 1.03 | 0.89 | 0.84 |
| Current Liabilities | 2.71 | 3.10 | 5.26 | 6.39 | 13.20 | 9.27 |
| Total Liabilities | 3.85 | 4.15 | 6.30 | 7.42 | 14.09 | 10.11 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | -7.02 | 5.07 | 6.94 | -6.08 | 7.02 | 15.32 |
| Cash from Investing Activities | 7.11 | -4.98 | -7.73 | -2.56 | -4.08 | -9.70 |
| Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 |
| Net Increase/Decrease in Cash | 0.09 | 0.09 | -0.79 | -8.64 | 2.95 | 5.56 |